文献速递生殖医学

多囊卵巢综合征女性冻融胚胎移植周期中使用来曲唑的研究

Letrozole use during frozen embryo transfer cycles in women with polycystic ovary syndrome.
PubMed 文献 · Fertil Steril · 2019-05-21

该回顾性队列研究纳入2011至2016年间2664例符合纳入标准的多囊卵巢综合征患者,比较来曲唑刺激周期冻融胚胎移植(L-FET)与人工周期冻融胚胎移植(AC-FET)的活产率。粗分析中两组活产率相似(L-FET 54.4% vs AC-FET 50.7%),但校正混杂因素后L-FET活产率显著高于AC-FET,且L-FET妊娠丢失率持续低于AC-FET。作者认为来曲唑用于内膜准备与更高活产率相关,需未来前瞻性随机研究验证。

要点

  • 校正混杂因素后,L-FET活产率显著高于AC-FET。
  • L-FET妊娠丢失率持续低于AC-FET(粗分析9.1% vs 17%)。
  • 作者建议未来需前瞻性随机研究验证该发现。

核心结论

  • 在多囊卵巢综合征患者冻融胚胎移植中,来曲唑用于内膜准备与较人工周期更高的活产率相关,但该结果来自统计校正混杂因素之后。
  • 作者建议未来需前瞻性随机研究验证本研究发现。

研究设计与样本

  • 回顾性队列研究,纳入2011年至2016年间2664例符合纳入标准的多囊卵巢综合征患者。
  • 研究比较来曲唑刺激周期冻融胚胎移植(L-FET)与人工周期冻融胚胎移植(AC-FET),主要结局为每移植周期活产率,并采用多因素logistic回归校正潜在混杂因素。

主要发现

  • 粗分析中,每移植周期活产率两组相似:L-FET组54.4% vs AC-FET组50.7%。
  • 粗分析中,L-FET组妊娠丢失率显著低于AC-FET组(9.1% vs 17%)。
  • 校正潜在混杂因素后,L-FET组活产率显著高于AC-FET组。
  • 校正后,L-FET组妊娠丢失率仍持续低于AC-FET组。

关键数值与推荐

  • 主要结局为每移植周期活产率;次要终点包括持续妊娠率、临床妊娠率、周期取消率、内膜厚度和妊娠丢失率。

临床怎么用

  • 原文未据此给出具体临床推荐。

局限性

  • 原文为回顾性队列研究。
  • 作者指出未来需前瞻性随机研究验证本研究发现。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To investigate whether live birth rate (LBR) following frozen-thawed embryo transfer in letrozole-stimulated cycles (L-FET) differs from LBR after artificial-cycle frozen-thawed embryos transfers (AC-FET) in women with polycystic ovary syndrome (PCOS). DESIGN: Retrospective cohort study. SETTING: Tertiary-care academic medical center. PATIENT(S): A total of 2,664 patients with PCOS who fulfilled the inclusion criteria were enrolled in the period from 2011 to 2016. INTERVENTIONS(S): Letrozole use versus hormone replacement therapies during FET. MAIN OUTCOME MEASURE(S): LBR per embryo transfer was the primary outcome. The secondary end points included ongoing and clinical pregnancy rate, cancellation rate, endometrial thickness, and pregnancy loss rate. Multivariable logistic regression analysis was performed to adjust for potential confounders. RESULT(S): In our crude analysis, LBR per embryo transfer was similar between groups (54.4% in the L-FET vs. 50.7% for the AC-FET). The crude odds of pregnancy loss was significantly lower in L-FET compared with AC-FET (9.1% vs. 17%). Nonetheless, after adjusting for possible confounding factors, LBR was significantly higher in L-FET compared with AC-FET. Moreover, the rates of pregnancy loss remained consistently lower in the L-FET group than in the AC-FET group. CONCLUSION(S): In patients with PCOS undergoing FET, letrozole use for endometrial preparation was associated with higher LBR compared with artificial cycles, albeit after statistical adjustment for confounding factors. Future prospective randomized studies are needed to verify our findings.

来源:Fertil Steril,查看原文。版权归原作者所有。

引用

  1. Zhang J, Liu H, Wang Y, et al. Letrozole use during frozen embryo transfer cycles in women with polycystic ovary syndrome. Fertil Steril. 2019. PMID: 31126712. doi:10.1016/j.fertnstert.2019.04.014

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。